Diadema Partners »

Design Therapeutics shares owned by Diadema Partners

Quarter-by-quarter ownership of Design Therapeutics (DSGN) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Design Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Design Therapeutics held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Design Therapeutics by Diadema Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $941k 100k 9.38

More positions owned by Diadema Partners

Viking Therapeutics (VKTX)
Vertex Pharmaceuticals Incorporated (VRTX)
Bridgebio Pharma (BBIO)
Spdr Series Trust State Street Spd Put Option (XBI)
Praxis Precision Medicines I Com New Put Option (PRAX)
Johnson & Johnson (JNJ)
Avidity Biosciences Ord Call Option (RNA)
Capricor Therapeutics Com New (CAPR)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Jazz Pharmaceuticals Shs Usd Call Option (JAZZ)
Terns Pharmaceuticals (TERN)
Apogee Therapeutics Call Option (APGE)
Structure Therapeutics Sponsored Ads Call Option (GPCR)
Regeneron Pharmaceuticals (REGN)
Abivax Sa Sponsored Ads (ABVX)

View all positions for Diadema Partners

Top funds holding Design Therapeutics

Sr One Capital Management
Point72 Asset Management
Logos Global Management
BlackRock
Baker Bros. Advisors
Vanguard Group
Vivo Capital
Almitas Capital
Driehaus Capital Management
Woodline Partners
Kynam Capital Management
FMR
Geode Capital Management
State Street Corporation
Acadian Asset Management

View all funds holding Design Therapeutics